4//SEC Filing
Koo Jakap 4
Accession 0001474506-25-000090
CIK 0001894525other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:58 PM ET
Size
5.2 KB
Accession
0001474506-25-000090
Insider Transaction Report
Form 4
Koo Jakap
Director
Transactions
- Purchase
Common Stock, par value $0.01 per share
2025-05-12$1.99/sh+28,500$56,715→ 643,885 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F2]These shares were sold in multiple transactions at prices ranging from $1.9774 to $2.2000, inclusive.
Documents
Issuer
Apimeds Pharmaceuticals US, Inc.
CIK 0001894525
Entity typeother
Related Parties
1- filerCIK 0002041972
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 5:58 PM ET
- Size
- 5.2 KB